Komori
General Meetings of Shareholders4553TOWA PHARMACEUTICAL CO.,LTD.Pharmaceuticals

Partial Correction to the Information Stated in the Notice of Convocation of the 70th Annual General Meeting of Shareholders

Article 11-6 of the proposed amendments to the Articles of Incorporation was supplemented with the method for acquiring a portion of the Class A Preferred Shares and the method for calculating the acquisition price per share.

Worth reading
2Immaterial
Scored from 2 of 3 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

The document this correction applies to

Timely disclosure
Notice of Convocation of the 70th Annual General Meeting of Shareholders2026-05-29

What was corrected and how

A subsequent correction by the company to the contents of an already published filing.

Original disclosure2026-05-29

Notice of Convocation of the 70th Annual General Meeting of Shareholders

Open the original document
26 daysThe pre-correction wording stayed published for this period (Calculated from the disclosure date of the linked filing)
This correction2026-06-24
Location of correction (where in the original document)

Reference Materials for the General Meeting of Shareholders, Proposal No. 2: Partial Amendments to the Articles of Incorporation (pages 16–17)

ChangesThe correction has added to the proposed amendments the method for acquiring a portion of the Class A Preferred Shares and the method for calculating the acquisition price per Class A Preferred Share.
Reason for correction

Certain matters stated in the Notice of Convocation of the 70th Annual General Meeting of Shareholders required partial correction.

What was corrected and how
ItemDetails
Disclosure subject to correctionNotice of Convocation of the 70th Annual General Meeting of Shareholders
Location of correctionReference Materials for the General Meeting of Shareholders, Proposal No. 2: Partial Amendments to the Articles of Incorporation (pages 16–17)
Details of correctionThe correction has added to the proposed amendments the method for acquiring a portion of the Class A Preferred Shares and the method for calculating the acquisition price per Class A Preferred Share.
Reason for correctionCertain matters stated in the Notice of Convocation of the 70th Annual General Meeting of Shareholders required partial correction.
Items this document does not state (2)
Original disclosure dateImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Certain matters stated in the Notice of Convocation of the 70th Annual General Meeting of Shareholders required partial correction.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Partial Correction to the Information Stated in the Notice of Convocation of the 70th Annual General Meeting of Shareholders | TOWA PHARMACEUTICAL CO.,LTD. (4553) timely disclosure | Komori